Generating real‐world evidence on diabetes technology using the CareLink Personal data management system
Authors' conclusion
RWE from CP adheres to the principles of RWE and can serve as robust evidence on the performance and safety of MiniMed systems.
Study context
- Population
- MiniMed system users with CareLink Personal (CP) accounts; last year's MiniMed 780G system data as case study
- Outcome
- CP fitness-for-research metrics
- Follow-up
- Last year
Methodological detailsreal-world database validation, case study of MiniMed 780G system data
- Real-world database validation
- Case study of MiniMed 780G system data
Performance
As reported in the abstract
- Users with a CP account
- Over 95%
- Users providing consent
- 96%
- Usable share of census population
- >91%
- Endpoints included in CP
- >50
- Mean data points per person per day (maximum 288, 5-min intervals)
- 263
- Automated uploads
- Ninety-nine per cent
- Users with a data gap >1 day
- 1 in 6
- Users with a data gap >1 week
- 1 in 50
Original publication
Generating real‐world evidence on diabetes technology using the CareLink Personal data management system. Diabetes Obes Metab. Published 4 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →